GNH USA

Europe — EMA

Numeta G19e

GNH USA supplies Numeta G19e (Amino Acid Blend), a parenteral nutrition solution for critical illness, postoperative recovery and neonatal care.

Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methio

Request sourcing

1
Pack/s

What is Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methio?

Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methionine, the active ingredient in Numeta G19e, is a parenteral nutrition solution presented as a sterile liquid for intravenous use. It supplies essential amino acids to support protein synthesis, nitrogen balance and metabolic needs in patients who cannot receive adequate nutrition orally, such as critically ill, postoperative or neonatal patients.

GNH USA supplies Numeta G19e as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methio used for?

Numeta G19e is an intravenous amino‑acid formulation used in clinical nutrition to address protein and nitrogen requirements across several patient groups.

- Critical illness: helps maintain nitrogen balance and supports muscle preservation. - Post‑operative recovery: provides substrates for wound healing and tissue repair. - Neonatal intensive care: delivers essential amino acids for growth and development in preterm infants.

What are the side effects of Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methio?

Adverse reactions may occur with any parenteral nutrition product. Monitoring during infusion is recommended.

Common Side Effects: - Phlebitis at the infusion site. - Mild electrolyte disturbances (e.g., hyperkalemia). - Transient increase in blood urea nitrogen. - Nausea or vomiting if infusion rate is too rapid. - Mild fever or chills during administration.

Serious or Rare Side Effects: - Severe hypersensitivity or anaphylactic reaction. - Metabolic acidosis. - Hyperammonemia in patients with liver dysfunction. - Hyperglycemia requiring insulin therapy. - Thrombophlebitis or catheter‑related infection.

What precautions apply to Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methio?

Use Numeta G19e only under medical supervision with appropriate laboratory monitoring.

- Assess renal and hepatic function: adjust infusion rate based on organ performance. - Monitor electrolytes and acid‑base status: correct imbalances promptly. - Avoid rapid infusion: follow recommended infusion rates to reduce phlebitis risk. - Use aseptic technique: prevent catheter‑related infections. - Contraindicated in patients with known hypersensitivity to any component. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methio interact with?

Amino‑acid solutions can interact with certain medications and clinical conditions.

Major Interactions (Avoid): - High‑dose corticosteroids: may increase catabolism and reduce amino‑acid utilization. - Certain diuretics (e.g., loop diuretics): can exacerbate electrolyte disturbances. - Incompatible IV drugs: avoid mixing with calcium‑containing solutions due to precipitation risk.

Moderate Interactions (Monitor Closely): - Insulin or oral hypoglycemics: monitor blood glucose as amino‑acid infusion may raise glucose levels. - Anticoagulants: watch for changes in coagulation parameters. - Renal replacement therapy: adjust dosing based on clearance. - Parenteral lipid emulsions: coordinate infusion schedules to prevent overload.

Frequently asked questions

What is Numeta G19e used for?+
Numeta G19e is an intravenous amino‑acid formulation used to provide essential building blocks for protein synthesis in patients who cannot meet their nutritional needs orally. It is commonly employed in critical care, postoperative recovery and neonatal intensive care to support tissue repair, growth and metabolic stability.
How does the amino‑acid blend in Numeta G19e work?+
The blend delivers a balanced profile of essential and conditionally essential amino acids directly into the bloodstream. Cells take up these amino acids and incorporate them into proteins, supporting anabolic processes, immune function and nitrogen balance while bypassing the gastrointestinal tract, which is crucial for patients with impaired digestion or absorption.
What is the usual dose of Numeta G19e?+
The dose of Numeta G19e is individualized by the prescribing clinician based on the patient’s weight, clinical condition, renal and hepatic function, and overall nutritional goals. Healthcare professionals calculate the appropriate infusion rate and total daily amount to meet the patient’s specific protein and caloric requirements.
Is Numeta G19e safe during pregnancy or breastfeeding?+
Numeta G19e is generally reserved for patients with a clear medical indication for parenteral nutrition. Its safety in pregnancy or lactation has not been specifically established, so it should only be used if the potential benefit justifies any possible risk, and under close medical supervision.
How do I order Numeta G19e from GNH USA?+
To order Numeta G19e, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain logistics if needed) and required import documentation.
How does Numeta G19e compare with other parenteral amino‑acid products?+
Numeta G19e offers a comprehensive amino‑acid profile designed for balanced protein synthesis, similar to other high‑quality parenteral nutrition solutions. Compared with older formulations that may lack certain essential amino acids, Numeta G19e provides a more physiologic composition, potentially improving nitrogen balance and reducing metabolic complications in critically ill patients.
What are the storage and handling requirements for Numeta G19e?+
Numeta G19e must be stored refrigerated at 2‑8 °C. Keep the vials in their original packaging, protect them from light, and avoid freezing or shaking the solution. Before administration, allow the product to reach room temperature if required by the clinical protocol.
How is Numeta G19e administered?+
Numeta G19e is administered intravenously, typically via a peripheral or central venous catheter. The infusion rate is set by the healthcare provider based on the patient’s nutritional prescription, and the solution is usually diluted in compatible IV fluids according to institutional guidelines.
What are the most serious risks associated with Numeta G19e?+
Serious risks include severe hypersensitivity reactions, metabolic acidosis, hyperammonemia in patients with liver dysfunction, and catheter‑related infections. Continuous monitoring of vital signs, laboratory parameters and infusion site is essential to detect and manage these complications promptly.
Who should not receive Numeta G19e?+
Numeta G19e should be avoided in patients with known hypersensitivity to any of its amino‑acid components, in those with uncontrolled metabolic disorders that could be worsened by amino‑acid infusion, and in individuals where a compatible IV solution is required to prevent precipitation. Clinical judgment is required for each case.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Valine, Ornithine Hydrochloride, Alanine, Arginine, Cysteine, Histidine, Isoleucine, Leucine, Methio
Route
Intravenous Use
Manufacturer
Baxter S.P.A.
Origin
EU